Hyliion Holdings Corp. (NYSE:HYLN - Get Free Report) insider Govindaraj Ramasamy purchased 20,000 shares of the company's stock in a transaction dated Friday, May 23rd. The shares were purchased at an average cost of $1.13 per share, for a total transaction of $22,600.00. Following the transaction, the insider now directly owns 573,002 shares in the company, valued at approximately $647,492.26. This represents a 3.62% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Hyliion Stock Performance
NYSE:HYLN traded down $0.07 during trading hours on Friday, reaching $1.54. The company's stock had a trading volume of 2,228,914 shares, compared to its average volume of 1,240,636. The company has a market capitalization of $269.22 million, a P/E ratio of -4.16 and a beta of 2.76. Hyliion Holdings Corp. has a 12 month low of $1.11 and a 12 month high of $4.10. The stock has a 50 day moving average price of $1.44 and a two-hundred day moving average price of $2.07.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded shares of Hyliion from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd.
Check Out Our Latest Analysis on Hyliion
Hedge Funds Weigh In On Hyliion
A number of large investors have recently bought and sold shares of HYLN. Cubist Systematic Strategies LLC acquired a new position in shares of Hyliion during the first quarter worth $26,000. Xponance Inc. acquired a new position in shares of Hyliion during the fourth quarter worth $29,000. Cibc World Markets Corp acquired a new position in shares of Hyliion during the fourth quarter worth $34,000. Aquatic Capital Management LLC acquired a new position in shares of Hyliion during the fourth quarter worth $42,000. Finally, Raymond James Financial Inc. acquired a new position in shares of Hyliion during the fourth quarter worth $43,000. Institutional investors own 22.81% of the company's stock.
Hyliion Company Profile
(
Get Free Report)
Featured Stories
Before you consider Hyliion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyliion wasn't on the list.
While Hyliion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
